MAXIGESIC® is a unique patented combination of paracetamol 500mg and ibuprofen 150mg, two tried and trusted active ingredients that work together in different, yet complementary ways to help relieve pain (paracetamol) and reduce fever and inflammation (ibuprofen) at the same time.
MAXIGESIC® was developed as a better alternative for pain relief than other combination analgesics, and as a more effective form of pain relief than paracetamol and ibuprofen; the two most common pain relief medications in Australia.
MAXIGESIC® was invented and developed Down Under by Hartley Atkinson, Australian-born pharmacologist and founder of AFT Pharmaceuticals. Introduced in Australia in 2014, this world-first specific combination analgesic now has license agreements in 130 countries around the world.
MAXIGESIC® provides temporary relief for a wide range of pain including:
• Migraine headache
• Tension headache
• Muscular pain
• Back pain
• Period Pain
• Rheumatic pain
• Pain from dental procedures
• Aches and pain associated with cold and flu
• Sinus pain
• Sore throat
• Tennis elbow
MAXIGESIC® also reduces fever and inflammation.
MAXIGESIC® is only available from pharmacies – ask your pharmacist about available pack sizes.
MAXIGESIC® is NOT recommended for children under 12 years of age.
Do not take MAXIGESIC® if:
Please review the MAXIGESIC® packaging for full directions and warnings.
Shop now ‣
WARNING: Do NOT combine with any other paracetamol or ibuprofen containing medicines. Do not exceed the daily recommended dose.
MAXIGESIC® film coated tablets (Paracetamol 500mg and Ibuprofen 150mg) are for the temporary relief of pain and reduction of fever. Do not use if you have asthma or a stomach ulcer. Do not use in children under 12 years or if you have kidney disease. Always read the label. Use only as directed. Incorrect use can be harmful. If symptoms persist consult your healthcare professional. AFT Pharmaceuticals Pty Ltd, Sydney. Patent No. 2005260243.